Search results
Showing results for
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
Srinivasa Rao Rao
MBBS, MS (res), DPhil, AFHEA Srinivasa Rao Rao - Senior Researcher in Cancer Genomics
Claudia Monaco
Claudia Monaco - Professor of Cardiovascular Inflammation
Ed Burn
Ed Burn - Senior Researcher in Epidemiology and Health Economics
Fernando Martinez Estrada
Fernando Martinez Estrada - Honorary Departmental Senior Research Associate
Kirsten Leyland
BA, MSc, DPhil Kirsten Leyland - HONORARY Postdoctoral Epidemiologist
Nasim Zargar
Nasim Zargar - Honorary Departmental Product Development Scientist and Senior Production Manager
Raashid Luqmani
DM FRCP, FRCP(E) Raashid Luqmani - Professor of Rheumatology
Alex Clarke
PhD FRCP Alex Clarke - Associate Professor and Honorary Consultant Rheumatologist, Nuffield Orthopaedic Centre
Steve Gwilym
MBBS, BSc, DPhil, FRCS (Tr & Orth) Steve Gwilym - Associate Professor & Consultant Orthopaedic Surgeon
Stephen Gerry
BSc, MSc Stephen Gerry - Senior Medical Statistician and NIHR Doctoral Research Fellow
Xavier Griffin
Xavier Griffin - Honorary Departmental Associate Professor of Trauma Surgery
James K-K Chan
MA(Cantab), DPhil(Oxon), FRCS(Plast) James K-K Chan - Honorary Departmental Clinical Lecturer